[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide

C46H60N8O3S2 — CID 159251542

IUPAC[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide
SMILESNC[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1.O=C(NC[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1)c1ccc2c(c1)OCO2
InChIInChI=1S/C27H32N4O3S.C19H28N4S/c32-27(19-9-10-23-24(15-19)34-18-33-23)28-16-20-5-1-2-6-21(20)17-30-11-13-31(14-12-30)26-22-7-3-4-8-25(22)35-29-26;20-13-15-5-1-2-6-16(15)14-22-9-11-23(12-10-22)19-17-7-3-4-8-18(17)24-21-19/h3-4,7-10,15,20-21H,1-2,5-6,11-14,16-18H2,(H,28,32);3-4,7-8,15-16H,1-2,5-6,9-14,20H2/t20-,21-;15-,16-/m00/s1
InChIKeyKVIZFYXKZYFFOX-ZPTXTSJUSA-N
MW837.17 g/mol
LogP7.57
Rot. Bonds10

About [(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide

[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide (PubChem CID 159251542) has the molecular formula C46H60N8O3S2 and a molecular weight of 837.17 g/mol. Its IUPAC name is [(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide.

Molecular Properties

Compound Name[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide
PubChem CID159251542
Molecular FormulaC46H60N8O3S2
Molecular Weight837.17 g/mol
Exact Mass836.42
IUPAC Name[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide
SMILESNC[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1.O=C(NC[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1)c1ccc2c(c1)OCO2
InChIInChI=1S/C27H32N4O3S.C19H28N4S/c32-27(19-9-10-23-24(15-19)34-18-33-23)28-16-20-5-1-2-6-21(20)17-30-11-13-31(14-12-30)26-22-7-3-4-8-25(22)35-29-26;20-13-15-5-1-2-6-16(15)14-22-9-11-23(12-10-22)19-17-7-3-4-8-18(17)24-21-19/h3-4,7-10,15,20-21H,1-2,5-6,11-14,16-18H2,(H,28,32);3-4,7-8,15-16H,1-2,5-6,9-14,20H2/t20-,21-;15-,16-/m00/s1
InChIKeyKVIZFYXKZYFFOX-ZPTXTSJUSA-N
XLogP7.57
TPSA112.32 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds10
Heavy Atoms59
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500837.17
LogP ≤ 57.57
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Analyze [(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide?
The IUPAC name of [(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide (CID 159251542) is [(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide.
What is the SMILES notation for [(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide?
The canonical SMILES for [(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide is NC[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1.O=C(NC[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1)c1ccc2c(c1)OCO2.
What is the InChIKey of [(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide?
The InChIKey is KVIZFYXKZYFFOX-ZPTXTSJUSA-N. The full InChI is InChI=1S/C27H32N4O3S.C19H28N4S/c32-27(19-9-10-23-24(15-19)34-18-33-23)28-16-20-5-1-2-6-21(20)17-30-11-13-31(14-12-30)26-22-7-3-4-8-25(22)35-29-26;20-13-15-5-1-2-6-16(15)14-22-9-11-23(12-10-22)19-17-7-3-4-8-18(17)24-21-19/h3-4,7-10,15,20-21H,1-2,5-6,11-14,16-18H2,(H,28,32);3-4,7-8,15-16H,1-2,5-6,9-14,20H2/t20-,21-;15-,16-/m00/s1.
What are the key properties of [(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide?
[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide has a molecular weight of 837.17 g/mol, XLogP of 7.57, 10 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methanamine;N-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-1,3-benzodioxole-5-carboxamide is sourced from PubChem (CID 159251542), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).